Industries > Pharma > Automation in Biopharma Industry 2020-2030

Automation in Biopharma Industry 2020-2030

Automation in Biopharma Industry 2020-2030: Forecasts by Application (Clinical Stage and Drug Discovery Stage) and by Technologies (Automation Technology (DCS, SCADA, PLC, MES, HMI, APC, ERP, LIMS, CRM, CAPA) and Digital Technology (IoT, AI, Digital Twin, AR & VR, Predictive Analytics, Cloud Computing). Plus, Leading Companies Analysis for Automation in Biopharma

PUBLISHED: 30 April 2020
PAGES: 142
PRODUCT CODE: PHA0455

WOOCS 2.2.1
DOWNLOAD FREE SAMPLE

The automation in biopharma industry market is estimated to grow at a CAGR of 4.3% over the forecast period.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

The 142-page Visiongain report provides clear detailed insight into the automation in biopharma market. Discover the key trends and development in the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope

• Global automation in biopharma market forecasts from 2020-2030

• This report also breaks down the revenue forecast to 2030 for the global automation in biopharma market by applications & leading technology type:

• By Application:
• Global automation and digital market in biopharmaceutical industry in clinical stage
• Global automation and digital market in biopharmaceutical industry in drug discovery stage

• By Technology:

• Automation Technology
• DCS
• SCADA
• PLC
• MES
• HMI
• APC
• ERP
• LIMS
• CRM
• CAPA

• Digitization Technology
• IoT
• AI
• Digital Twin
• AR & VR
• Predictive Analytics
• Cloud Computing

This report discusses the market trends and developments of each submarket.

• Our study discusses the selected leading companies that are the major players in the automation in biopharma market:
• PerkinElmer
• Thermo Fisher Scientific
• Sartorius
• Siemens
• Rockwell Automation
• & Other Companies

Visiongain’s study is intended for anyone requiring commercial analyses for the global automation in biopharma market. You find data, trends and predictions.

Buy our report today Automation in Biopharma Industry  Research 2020-2030: Forecasts by Application (Clinical Stage and Drug Discovery Stage) and by Technologies (Automation Technology (DCS, SCADA, PLC, MES, HMI, APC, ERP, LIMS, CRM, CAPA) and Digital Technology (IoT, AI, Digital Twin, AR & VR, Predictive Analytics, Cloud Computing). Plus, Leading Companies Analysis. Avoid missing out by staying informed – order our report now.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Do you have any custom requirements we can help you with? Any need for specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com

Download sample pages

Complete the form below to download your free sample pages for Automation in Biopharma Industry 2020-2030


Download sample pages

Complete the form below to download your free sample pages for Automation in Biopharma Industry 2020-2030


Latest Pharma news

Visiongain Publishes Macular Degeneration (AMD) and Other Retinal Diseases Drugs Market Report 2022-2032

The Macular Degeneration (AMD) and Other Retinal Diseases Drugs market was valued at US$25.29 billion in 2021 and is projected to grow at a CAGR of 7.87% during the forecast period 2022-2032.

25 November 2022

READ

Visiongain Publishes Top 50 Pharmaceutical Contract Manufacturing Organisations (CMOs) Market Report 2022

Pharmaceutical Contract Manufacturing Organisations (CMOs) market is projected to grow at a CAGR of 6.9% by 2032.

25 November 2022

READ

Visiongain Publishes Dermatology CROs Market Report 2022-2032

The Dermatology CROs market was valued at US$ 5,154.8 million in 2021 and is projected to grow at a CAGR of 8.7% during the forecast period 2022-2032.

23 November 2022

READ

Visiongain Publishes Direct-to-Patient Market Report 2022-2032

The Direct-to-Patient market was valued at US$38,651 million in 2021 and is projected to grow at a CAGR of 6.1% during the forecast period 2022-2032.

22 November 2022

READ